This video reviews the use of PD-L1 testing in selecting patients for frontline lung cancer treatment with pembrolizumab and examines which patients might not be appropriate for immunotherapy.
In this video, Aaron S. Mansfield, MD, of the Mayo Clinic in Rochester, Minnesota, reviews PD-L1 testing in selecting patients for frontline lung cancer treatment with pembrolizumab, and discusses which patients might not be appropriate for immunotherapy.
Mansfield spoke on this topic last month at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
Advancing Thoracic Surgery With Robotics and Video-Assisted Strategies
June 13th 2024"Anything that you can do to leverage technology to minimize the variability in surgery eliminates the skill gap so that novice surgeons may become as technically gifted as the intermediate surgeon or the master surgeon."